High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying Kids – TheStreet.com
TheStreet.com |
High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying Kids
TheStreet.com A small drug company flies to Washington, DC for a high-stakes meeting with FDA officials. If the meeting goes well, the company secures the permission of regulators to start a pivotal clinical trial for a therapy designed to treat kids with a rare … AveXis Inc (AVXS) Sees Large Decrease in Short Interest |
